[A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group]. [electronic resource]
Producer: 19910612Description: 1013-9 p. digitalISSN:- 0385-0684
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Anorexia -- chemically induced
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Camptothecin -- administration & dosage
- Carcinoma, Small Cell -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Drug Evaluation
- Female
- Humans
- Infusions, Intravenous
- Irinotecan
- Leukopenia -- chemically induced
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Nausea -- chemically induced
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.